Advertisement
Canada markets close in 2 hours 29 minutes
  • S&P/TSX

    21,655.40
    -0.65 (-0.00%)
     
  • S&P 500

    5,016.20
    -6.01 (-0.12%)
     
  • DOW

    37,747.97
    -5.34 (-0.01%)
     
  • CAD/USD

    0.7261
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    82.98
    +0.29 (+0.35%)
     
  • Bitcoin CAD

    87,211.98
    +3,495.62 (+4.18%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,399.70
    +11.30 (+0.47%)
     
  • RUSSELL 2000

    1,954.04
    +6.09 (+0.31%)
     
  • 10-Yr Bond

    4.6490
    +0.0640 (+1.40%)
     
  • NASDAQ

    15,646.38
    -36.99 (-0.24%)
     
  • VOLATILITY

    17.98
    -0.23 (-1.27%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6815
    +0.0013 (+0.19%)
     

NetworkNewsAudio Announces an Audio Press Release (APR) on Lexaria Bioscience Corp. and its Potential Disruption in Nicotine Delivery

New York, New York--(Newsfile Corp. - March 8, 2018) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Smokers Light Up Less, Alternative Nicotine Delivery Technologies Take Center Stage," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).

To hear the NetworkNewsAudio version, visit: http://nnw.fm/qwD6f

To read the original editorial, visit http://nnw.fm/P63Rk

At present, Lexaria is the only company in the world that has been awarded patents for the improved (oral or ingestible, including pills) delivery of all cannabinoids both psychoactive and non. These patents have been awarded in the United States and Australia and are pending in 40 more countries. This puts the company in the unusually advantageous position of owning proprietary technology that can deliver a vast range of cannabinoid-based drugs.

The company recently received a new patent award in the U.S. that also protects its delivery system for use with nicotine, potentially offering the biggest disruption to nicotine delivery since the invention of the cigarette.

"Lexaria has now locked-up the IP for its next-generation drug delivery system" Lexaria CEO Chris Bunka explained in the press release (http://nnw.fm/Q8JxJ). "This ground-breaking, patented IP builds a foundation for new business opportunities in 2018 including what could be the world's first nicotine edibles for the smokeless tobacco industry, or improved new products for NSAID-derived pain management, as well as in the rapidly growing cannabis market."

ADVERTISEMENT

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit www.LexariaEnergy.com.

About NetworkNewsAudio

NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we're watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.

For more information, visit: www.NetworkNewsAudio.com

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
Editor@NetworkNewsWire.com